Table 3.
Cachexia measures and assessments
| Variable | n (%) | Median (IQR) |
|---|---|---|
| Weight (kg) | 24 | 66.7 kg (± 14.1)* |
| Height (m) | 24 | 1.69 m (± 0.09)* |
| BMI (kg/m2) | 24 | 23.4 (± 4.7)* |
| < 18.5 | 4 (17) | |
| 18.5–24.9 | 12 (50) | |
| 25–29.9 | 6 (25) | |
| ≥ 30 | 2 (8) | |
| Weight loss in previous 6 months (%) | 23 | 6.7 (0.5–17.0) |
| < 5% | 9 (38) | |
| 5–10% | 5 (21) | |
| > 10% | 9 (38) | |
| Skeletal muscle area L3 (cm2) | 19 | 121.7 (103.3–154.7) |
| Total adipose tissue area L3 (cm2) | 19 | 289.1 (104.0–402.6) |
| Skeletal muscle index L3 (cm2/m2) | 19 | 42.9 (40.2–50.4) |
| Adipose tissue index L3 (cm2/m2) | 19 | 101.6 (33.2–157.3) |
| Sarcopenia | ||
| Yes | 12 (50) | |
| No | 7 (29) | |
| Hand grip strength (kg) | 24 | 20.2 (15.7–26.8) |
| ESAS appetite score | 24 | 4.5 (0.3–6.8) |
| Patient-Generated Subjective Global Assessment | ||
| 0 | 4 (17) | |
| 1 | 9 (38) | |
| 2 | 7 (29) | |
| 3 | 4 (17) | |
| CRP (mg/L) | 19 | 43.0 (5.0–82.0) |
| Albumin (mg/L) | 21 | 39.0 (34.5–41.5) |
| Haemoglobin (g/L) | 21 | 124.0 (107.5–143.5) |
| White cell count (× 10 × 9/L) | 22 | 11.3 (8.6–16.8) |
| Performance status | ||
| 0 | 12 (50) | |
| 1 | 2 (8) | |
| 2 | 6 (25) | |
| 3 | 4 (17) | |
Median and IQR are reported except where the asterisk symbol indicates mean and SD